{"transactions":[{"id":808662,"issuer":{"id":2018,"kind":"organization","name":"VERACYTE, INC.","symbol":"VCYT"},"owners":[{"id":52522,"kind":"person","name":"Haas Kevin Richard","position":1,"cik":"0001843872","reported_name":"Haas Kevin Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Dev and Tech Officer"}}],"security":"Common Stock","published_at":"2026-04-14T21:03:21.000Z","date":"2026-04-10","kind":"grant","planned":false,"acquired":true,"shares":44221,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Restricted stock units awarded on April 10, 2026 vest 25% on June 2, 2027 and 1/16 per quarter thereafter subject to continuing employment of the Reporting Person on each vesting date."}],"balance_after":44221,"source":{"system":"sec-edgar","filing":"0001843872-26-000011","document":"wk-form4_1776200598.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1384101/000184387226000011/wk-form4_1776200598.xml","form_type":"4"}},{"id":842675,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":52522,"kind":"person","name":"Haas Kevin Richard","position":1,"cik":"0001843872","reported_name":"Haas Kevin Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2026-03-16T21:58:00.000Z","date":"2026-03-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":8382,"price":4.66,"value":39060.12,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares of Common Stock withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of performance-based restricted stock units previously granted to the Reporting Person. The number of shares withheld was determined based on the closing price of the Issuer's Common Stock on March 13, 2026."}],"balance_after":180022,"source":{"system":"sec-edgar","filing":"0001843872-26-000005","document":"wk-form4_1773698278.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/899923/000184387226000005/wk-form4_1773698278.xml","form_type":"4"}},{"id":842674,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":52522,"kind":"person","name":"Haas Kevin Richard","position":1,"cik":"0001843872","reported_name":"Haas Kevin Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2026-03-16T21:58:00.000Z","date":"2026-03-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":3355,"price":4.66,"value":15634.3,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of Common Stock withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units previously granted to the Reporting Person. The number of shares withheld was determined based on the closing price of Issuer's Common Stock on March 13, 2026."}],"balance_after":188404,"source":{"system":"sec-edgar","filing":"0001843872-26-000005","document":"wk-form4_1773698278.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/899923/000184387226000005/wk-form4_1773698278.xml","form_type":"4"}},{"id":842673,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":52522,"kind":"person","name":"Haas Kevin Richard","position":1,"cik":"0001843872","reported_name":"Haas Kevin Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2026-03-16T21:58:00.000Z","date":"2026-03-14","kind":"tax_withholding","planned":false,"acquired":false,"shares":4161,"price":4.66,"value":19390.26,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of Common Stock withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units previously granted to the Reporting Person. The number of shares withheld was determined based on the closing price of Issuer's Common Stock on March 13, 2026."}],"balance_after":191759,"source":{"system":"sec-edgar","filing":"0001843872-26-000005","document":"wk-form4_1773698278.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/899923/000184387226000005/wk-form4_1773698278.xml","form_type":"4"}},{"id":842672,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":52522,"kind":"person","name":"Haas Kevin Richard","position":1,"cik":"0001843872","reported_name":"Haas Kevin Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2026-03-16T21:58:00.000Z","date":"2026-03-13","kind":"tax_withholding","planned":false,"acquired":false,"shares":6412,"price":4.66,"value":29879.92,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of Common Stock withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units previously granted to the Reporting Person. The number of shares withheld was determined based on the closing price of Issuer's Common Stock on March 13, 2026."}],"balance_after":195920,"source":{"system":"sec-edgar","filing":"0001843872-26-000005","document":"wk-form4_1773698278.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000184387226000005/wk-form4_1773698278.xml","form_type":"4"}},{"id":922970,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":52522,"kind":"person","name":"Haas Kevin Richard","position":1,"cik":"0001843872","reported_name":"Haas Kevin Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2026-02-03T22:29:58.000Z","date":"2026-02-02","kind":"grant","planned":false,"acquired":true,"shares":23697,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of performance-based restricted stock units (PSUs) initially granted on March 15, 2023, subject to accomplishment of pre-determined performance metrics. On February 2, 2026, the Compensation and Human Capital Committee of the Company's Board of Directors determined the final award amount based on the accomplishment of the applicable performance metrics. Each PSU represents a contingent right to receive one share of the Company's common stock and vests on March 15, 2026."}],"balance_after":202332,"source":{"system":"sec-edgar","filing":"0001843872-26-000003","document":"wk-form4_1770157795.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000184387226000003/wk-form4_1770157795.xml","form_type":"4"}},{"id":1192726,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":52522,"kind":"person","name":"Haas Kevin Richard","position":1,"cik":"0001843872","reported_name":"Haas Kevin Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2025-03-25T20:17:02.000Z","date":"2025-03-24","kind":"tax_withholding","planned":false,"acquired":false,"shares":1724,"price":9.98,"value":17205.52,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of performance-based restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on March 24, 2025."}],"balance_after":178635,"source":{"system":"sec-edgar","filing":"0001628280-25-014727","document":"wk-form4_1742933813.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/899923/000162828025014727/wk-form4_1742933813.xml","form_type":"4"}},{"id":1192725,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":52522,"kind":"person","name":"Haas Kevin Richard","position":1,"cik":"0001843872","reported_name":"Haas Kevin Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2025-03-25T20:17:02.000Z","date":"2025-03-24","kind":"tax_withholding","planned":false,"acquired":false,"shares":1177,"price":9.98,"value":11746.46,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on March 24, 2025."}],"balance_after":180359,"source":{"system":"sec-edgar","filing":"0001628280-25-014727","document":"wk-form4_1742933813.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/899923/000162828025014727/wk-form4_1742933813.xml","form_type":"4"}},{"id":1192724,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":52522,"kind":"person","name":"Haas Kevin Richard","position":1,"cik":"0001843872","reported_name":"Haas Kevin Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2025-03-25T20:17:02.000Z","date":"2025-03-22","kind":"tax_withholding","planned":false,"acquired":false,"shares":4493,"price":10.01,"value":44974.93,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of performance-based restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on March 21, 2025."}],"balance_after":181536,"source":{"system":"sec-edgar","filing":"0001628280-25-014727","document":"wk-form4_1742933813.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/899923/000162828025014727/wk-form4_1742933813.xml","form_type":"4"}},{"id":1192723,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":52522,"kind":"person","name":"Haas Kevin Richard","position":1,"cik":"0001843872","reported_name":"Haas Kevin Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2025-03-25T20:17:02.000Z","date":"2025-03-22","kind":"tax_withholding","planned":false,"acquired":false,"shares":1694,"price":10.01,"value":16956.94,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on March 21, 2025."}],"balance_after":186029,"source":{"system":"sec-edgar","filing":"0001628280-25-014727","document":"wk-form4_1742933813.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000162828025014727/wk-form4_1742933813.xml","form_type":"4"}},{"id":1204844,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":52522,"kind":"person","name":"Haas Kevin Richard","position":1,"cik":"0001843872","reported_name":"Haas Kevin Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2025-03-17T20:20:09.000Z","date":"2025-03-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":3335,"price":10.07,"value":33583.45,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on March 14, 2025."}],"balance_after":187723,"source":{"system":"sec-edgar","filing":"0001628280-25-013151","document":"wk-form4_1742242801.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/899923/000162828025013151/wk-form4_1742242801.xml","form_type":"4"}},{"id":1204843,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":52522,"kind":"person","name":"Haas Kevin Richard","position":1,"cik":"0001843872","reported_name":"Haas Kevin Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2025-03-17T20:20:09.000Z","date":"2025-03-14","kind":"tax_withholding","planned":false,"acquired":false,"shares":4390,"price":10.07,"value":44207.3,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on March 14, 2025."}],"balance_after":191058,"source":{"system":"sec-edgar","filing":"0001628280-25-013151","document":"wk-form4_1742242801.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/899923/000162828025013151/wk-form4_1742242801.xml","form_type":"4"}},{"id":1204842,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":52522,"kind":"person","name":"Haas Kevin Richard","position":1,"cik":"0001843872","reported_name":"Haas Kevin Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2025-03-17T20:20:09.000Z","date":"2025-03-13","kind":"grant","planned":false,"acquired":true,"shares":54124,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of time-based restricted stock units granted pursuant to the Company's 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests in three equal annual installments beginning on the first anniversary of the grant date."}],"balance_after":195448,"source":{"system":"sec-edgar","filing":"0001628280-25-013151","document":"wk-form4_1742242801.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000162828025013151/wk-form4_1742242801.xml","form_type":"4"}},{"id":1232256,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":52522,"kind":"person","name":"Haas Kevin Richard","position":1,"cik":"0001843872","reported_name":"Haas Kevin Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2025-03-05T00:31:40.000Z","date":"2025-02-07","kind":"grant","planned":false,"acquired":true,"shares":12758,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of performance-based restricted stock units (PSUs) initially granted on March 22, 2022, subject to accomplishment of pre-determined performance metrics. On February 7, 2025, the Compensation and Human Capital Committee of the Company's Board of Directors determined the final award amount based on the accomplishment of the applicable performance metrics. Each PSU represents a contingent right to receive one share of the Company's common stock and vests on March 22, 2025."}],"balance_after":141324,"source":{"system":"sec-edgar","filing":"0001628280-25-010138","document":"wk-form4_1741134694.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000162828025010138/wk-form4_1741134694.xml","form_type":"4"}},{"id":1244198,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":52522,"kind":"person","name":"Haas Kevin Richard","position":1,"cik":"0001843872","reported_name":"Haas Kevin Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2025-02-26T21:21:10.000Z","date":"2025-02-25","kind":"tax_withholding","planned":false,"acquired":false,"shares":1016,"price":11.74,"value":11927.84,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on February 25, 2025."}],"balance_after":128566,"source":{"system":"sec-edgar","filing":"0001843872-25-000002","document":"wk-form4_1740604855.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000184387225000002/wk-form4_1740604855.xml","form_type":"4"}},{"id":1388306,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":52522,"kind":"person","name":"Haas Kevin Richard","position":1,"cik":"0001843872","reported_name":"Haas Kevin Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2024-10-10T20:31:11.000Z","date":"2024-10-09","kind":"tax_withholding","planned":false,"acquired":false,"shares":2515,"price":24.37,"value":61290.55,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on October 9, 2024."}],"balance_after":129582,"source":{"system":"sec-edgar","filing":"0001843872-24-000004","document":"wk-form4_1728592265.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000184387224000004/wk-form4_1728592265.xml","form_type":"4"}},{"id":1562551,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":52522,"kind":"person","name":"Haas Kevin Richard","position":1,"cik":"0001843872","reported_name":"Haas Kevin Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2024-03-25T20:31:35.000Z","date":"2024-03-24","kind":"tax_withholding","planned":false,"acquired":false,"shares":1718,"price":22.24,"value":38208.32,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of performance-based restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on March 22, 2024."}],"balance_after":132097,"source":{"system":"sec-edgar","filing":"0001628280-24-012917","document":"wk-form4_1711398681.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/899923/000162828024012917/wk-form4_1711398681.xml","form_type":"4"}},{"id":1562550,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":52522,"kind":"person","name":"Haas Kevin Richard","position":1,"cik":"0001843872","reported_name":"Haas Kevin Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2024-03-25T20:31:35.000Z","date":"2024-03-24","kind":"tax_withholding","planned":false,"acquired":false,"shares":1172,"price":22.24,"value":26065.28,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on March 22, 2024."}],"balance_after":133815,"source":{"system":"sec-edgar","filing":"0001628280-24-012917","document":"wk-form4_1711398681.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/899923/000162828024012917/wk-form4_1711398681.xml","form_type":"4"}},{"id":1562549,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":52522,"kind":"person","name":"Haas Kevin Richard","position":1,"cik":"0001843872","reported_name":"Haas Kevin Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2024-03-25T20:31:35.000Z","date":"2024-03-22","kind":"tax_withholding","planned":false,"acquired":false,"shares":1685,"price":22.24,"value":37474.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on March 22, 2024."}],"balance_after":134987,"source":{"system":"sec-edgar","filing":"0001628280-24-012917","document":"wk-form4_1711398681.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000162828024012917/wk-form4_1711398681.xml","form_type":"4"}},{"id":1573563,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":52522,"kind":"person","name":"Haas Kevin Richard","position":1,"cik":"0001843872","reported_name":"Haas Kevin Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2024-03-18T20:45:49.000Z","date":"2024-03-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":3306,"price":21.16,"value":69954.96,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on March 15, 2024."}],"balance_after":136672,"source":{"system":"sec-edgar","filing":"0001628280-24-011685","document":"wk-form4_1710794740.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/899923/000162828024011685/wk-form4_1710794740.xml","form_type":"4"}},{"id":1573562,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":52522,"kind":"person","name":"Haas Kevin Richard","position":1,"cik":"0001843872","reported_name":"Haas Kevin Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2024-03-18T20:45:49.000Z","date":"2024-03-14","kind":"grant","planned":false,"acquired":true,"shares":35178,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Consists of time-based restricted stock units granted pursuant to the Company's 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests in three equal annual installments beginning on the first anniversary of the grant date."}],"balance_after":139978,"source":{"system":"sec-edgar","filing":"0001628280-24-011685","document":"wk-form4_1710794740.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000162828024011685/wk-form4_1710794740.xml","form_type":"4"}},{"id":1620563,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":52522,"kind":"person","name":"Haas Kevin Richard","position":1,"cik":"0001843872","reported_name":"Haas Kevin Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2024-02-26T21:12:36.000Z","date":"2024-02-25","kind":"tax_withholding","planned":false,"acquired":false,"shares":881,"price":22.72,"value":20016.32,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on February 23, 2024."}],"balance_after":104800,"source":{"system":"sec-edgar","filing":"0001843872-24-000002","document":"wk-form4_1708981929.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000184387224000002/wk-form4_1708981929.xml","form_type":"4"}},{"id":1762969,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":52522,"kind":"person","name":"Haas Kevin Richard","position":1,"cik":"0001843872","reported_name":"Haas Kevin Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2023-10-10T20:17:40.000Z","date":"2023-10-09","kind":"tax_withholding","planned":false,"acquired":false,"shares":1710,"price":15.01,"value":25667.1,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on October 9, 2023."}],"balance_after":105681,"source":{"system":"sec-edgar","filing":"0001843872-23-000006","document":"wk-form4_1696969050.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000184387223000006/wk-form4_1696969050.xml","form_type":"4"}},{"id":1772856,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":52522,"kind":"person","name":"Haas Kevin Richard","position":1,"cik":"0001843872","reported_name":"Haas Kevin Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2023-09-27T20:21:25.000Z","date":"2023-09-26","kind":"tax_withholding","planned":false,"acquired":false,"shares":858,"price":15.99,"value":13719.42,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on September 26, 2023."}],"balance_after":107391,"source":{"system":"sec-edgar","filing":"0001843872-23-000004","document":"wk-form4_1695846072.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000184387223000004/wk-form4_1695846072.xml","form_type":"4"}},{"id":1938401,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":52522,"kind":"person","name":"Haas Kevin Richard","position":1,"cik":"0001843872","reported_name":"Haas Kevin Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2023-03-27T20:28:12.000Z","date":"2023-03-24","kind":"tax_withholding","planned":false,"acquired":false,"shares":1674,"price":23.72,"value":39707.28,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of performance-based restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on March 24, 2023."}],"balance_after":108249,"source":{"system":"sec-edgar","filing":"0001628280-23-009263","document":"wf-form4_167994888071580.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/899923/000162828023009263/wf-form4_167994888071580.xml","form_type":"4"}},{"id":1938400,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":52522,"kind":"person","name":"Haas Kevin Richard","position":1,"cik":"0001843872","reported_name":"Haas Kevin Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2023-03-27T20:28:12.000Z","date":"2023-03-24","kind":"tax_withholding","planned":false,"acquired":false,"shares":1142,"price":23.72,"value":27088.24,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on March 24, 2023."}],"balance_after":109923,"source":{"system":"sec-edgar","filing":"0001628280-23-009263","document":"wf-form4_167994888071580.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000162828023009263/wf-form4_167994888071580.xml","form_type":"4"}},{"id":1940672,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":52522,"kind":"person","name":"Haas Kevin Richard","position":1,"cik":"0001843872","reported_name":"Haas Kevin Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2023-03-23T20:28:56.000Z","date":"2023-03-22","kind":"tax_withholding","planned":false,"acquired":false,"shares":1677,"price":22.91,"value":38420.07,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on March 22, 2023."}],"balance_after":111065,"source":{"system":"sec-edgar","filing":"0001628280-23-009050","document":"wf-form4_167960331971225.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000162828023009050/wf-form4_167960331971225.xml","form_type":"4"}},{"id":1950939,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":52522,"kind":"person","name":"Haas Kevin Richard","position":1,"cik":"0001843872","reported_name":"Haas Kevin Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2023-03-16T20:29:58.000Z","date":"2023-03-15","kind":"grant","acquired":true,"shares":28459,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Consists of time-based restricted stock units granted pursuant to the Company's 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests in three equal annual installments beginning on the first anniversary of the grant date."}],"balance_after":112742,"source":{"system":"sec-edgar","filing":"0001628280-23-008319","document":"wf-form4_167899858730951.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000162828023008319/wf-form4_167899858730951.xml","form_type":"4"}},{"id":1991324,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":52522,"kind":"person","name":"Haas Kevin Richard","position":1,"cik":"0001843872","reported_name":"Haas Kevin Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2023-02-27T21:08:07.000Z","date":"2023-02-25","kind":"tax_withholding","acquired":false,"shares":1012,"price":18.54,"value":18762.48,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on February 24, 2023."}],"balance_after":84283,"source":{"system":"sec-edgar","filing":"0001843872-23-000001","document":"wf-form4_167753204919533.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000184387223000001/wf-form4_167753204919533.xml","form_type":"4"}},{"id":2139692,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":52522,"kind":"person","name":"Haas Kevin Richard","position":1,"cik":"0001843872","reported_name":"Haas Kevin Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2022-10-11T20:33:50.000Z","date":"2022-10-09","kind":"tax_withholding","acquired":false,"shares":1721,"price":19.62,"value":33766.02,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on October 7, 2022."}],"balance_after":85295,"source":{"system":"sec-edgar","filing":"0001628280-22-026249","document":"wf-form4_166552041395150.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000162828022026249/wf-form4_166552041395150.xml","form_type":"4"}},{"id":2150771,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":52522,"kind":"person","name":"Haas Kevin Richard","position":1,"cik":"0001843872","reported_name":"Haas Kevin Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2022-09-27T20:32:48.000Z","date":"2022-09-26","kind":"tax_withholding","acquired":false,"shares":862,"price":18.41,"value":15869.42,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on September 26, 2022."}],"balance_after":87016,"source":{"system":"sec-edgar","filing":"0001628280-22-025567","document":"wf-form4_166431075031059.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/899923/000162828022025567/wf-form4_166431075031059.xml","form_type":"4"}},{"id":2150770,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":52522,"kind":"person","name":"Haas Kevin Richard","position":1,"cik":"0001843872","reported_name":"Haas Kevin Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2022-09-27T20:32:48.000Z","date":"2022-09-25","kind":"tax_withholding","acquired":false,"shares":346,"price":18.69,"value":6466.74,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on September 23, 2022."}],"balance_after":87878,"source":{"system":"sec-edgar","filing":"0001628280-22-025567","document":"wf-form4_166431075031059.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000162828022025567/wf-form4_166431075031059.xml","form_type":"4"}},{"id":2318213,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":52522,"kind":"person","name":"Haas Kevin Richard","position":1,"cik":"0001843872","reported_name":"Haas Kevin Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2022-03-25T21:08:48.000Z","date":"2022-03-24","kind":"tax_withholding","acquired":false,"shares":1689,"price":25.32,"value":42765.48,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of performance-based restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on March 24, 2022."}],"balance_after":88224,"source":{"system":"sec-edgar","filing":"0001843872-22-000008","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/899923/000184387222000008/edgardoc.xml","form_type":"4"}},{"id":2318212,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":52522,"kind":"person","name":"Haas Kevin Richard","position":1,"cik":"0001843872","reported_name":"Haas Kevin Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2022-03-25T21:08:48.000Z","date":"2022-03-24","kind":"tax_withholding","acquired":false,"shares":1153,"price":25.32,"value":29193.96,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on March 24, 2022."}],"balance_after":89913,"source":{"system":"sec-edgar","filing":"0001843872-22-000008","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000184387222000008/edgardoc.xml","form_type":"4"}},{"id":2320470,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":52522,"kind":"person","name":"Haas Kevin Richard","position":1,"cik":"0001843872","reported_name":"Haas Kevin Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2022-03-23T20:59:06.000Z","date":"2022-03-22","kind":"grant","acquired":true,"shares":19238,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Consists of time-based restricted stock units granted pursuant to the Company's 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests in four equal annual installments beginning on the first anniversary of the grant date."}],"balance_after":91066,"source":{"system":"sec-edgar","filing":"0001843872-22-000006","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000184387222000006/edgardoc.xml","form_type":"4"}},{"id":2370065,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":52522,"kind":"person","name":"Haas Kevin Richard","position":1,"cik":"0001843872","reported_name":"Haas Kevin Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2022-02-28T22:02:15.000Z","date":"2022-02-25","kind":"tax_withholding","acquired":false,"shares":865,"price":24.69,"value":21356.85,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person on February 18, 2021. The restricted stock units granted on February 18, 2021 represent a contingent right to receive one share of the Company's common stock and vested 25% on February 25, 2022 and vests 25% on February 25, 2023, 25% on February 25, 2024, and 25% on February 25, 2025. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on February 25, 2022."}],"balance_after":71828,"source":{"system":"sec-edgar","filing":"0001843872-22-000004","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000184387222000004/edgardoc.xml","form_type":"4"}},{"id":2386452,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":52522,"kind":"person","name":"Haas Kevin Richard","position":1,"cik":"0001843872","reported_name":"Haas Kevin Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2022-02-18T22:19:43.000Z","date":"2022-02-16","kind":"grant","acquired":true,"shares":19520,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Consists of performance-based restricted stock units (PSUs) granted pursuant to the Company's 2017 Employee, Director and Consultant Equity Incentive Plan. The PSUs were initially granted on March 24, 2021, subject to accomplishment of pre-determined performance metrics.  On February 16, 2022, the Compensation and Human Capital Committee determined the final award amount based on the accomplishment of the applicable performance metrics.  Each PSU represents a contingent right to receive one share of the Company's common stock, and vests 25% on March 24, 2022, 25% on March 24, 2023, 25% on March 24, 2024, and 25% on March 24, 2025."}],"balance_after":72693,"source":{"system":"sec-edgar","filing":"0001843872-22-000002","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000184387222000002/edgardoc.xml","form_type":"4"}},{"id":2544927,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":52522,"kind":"person","name":"Haas Kevin Richard","position":1,"cik":"0001843872","reported_name":"Haas Kevin Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2021-10-12T20:39:08.000Z","date":"2021-10-09","kind":"tax_withholding","acquired":false,"shares":1729,"price":30.88,"value":53391.52,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on October 8, 2021."}],"balance_after":53173,"source":{"system":"sec-edgar","filing":"0001843872-21-000015","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000184387221000015/edgardoc.xml","form_type":"4"}},{"id":2559323,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":52522,"kind":"person","name":"Haas Kevin Richard","position":1,"cik":"0001843872","reported_name":"Haas Kevin Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2021-09-27T23:54:44.000Z","date":"2021-09-26","kind":"tax_withholding","acquired":false,"shares":865,"price":33.31,"value":28813.15,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on September 24, 2021."}],"balance_after":54902,"source":{"system":"sec-edgar","filing":"0001843872-21-000013","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/899923/000184387221000013/edgardoc.xml","form_type":"4"}},{"id":2559322,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":52522,"kind":"person","name":"Haas Kevin Richard","position":1,"cik":"0001843872","reported_name":"Haas Kevin Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2021-09-27T23:54:44.000Z","date":"2021-09-25","kind":"tax_withholding","acquired":false,"shares":346,"price":33.31,"value":11525.26,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on September 24, 2021."}],"balance_after":55767,"source":{"system":"sec-edgar","filing":"0001843872-21-000013","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000184387221000013/edgardoc.xml","form_type":"4"}},{"id":2684620,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":52522,"kind":"person","name":"Haas Kevin Richard","position":1,"cik":"0001843872","reported_name":"Haas Kevin Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2021-06-03T22:42:10.000Z","date":"2021-05-28","kind":"grant","acquired":true,"shares":344,"price":15.861,"value":5456.184,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were acquired under the Myriad Genetics, Inc. 2012 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":56113,"source":{"system":"sec-edgar","filing":"0001843872-21-000011","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000184387221000011/edgardoc.xml","form_type":"4"}},{"id":2771108,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":52522,"kind":"person","name":"Haas Kevin Richard","position":1,"cik":"0001843872","reported_name":"Haas Kevin Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2021-03-26T20:33:58.000Z","date":"2021-03-24","kind":"grant","acquired":true,"shares":13326,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Consists of time-based restricted stock units granted pursuant to the Company's 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests in four equal annual installments beginning on the first anniversary of the grant date."}],"balance_after":55769,"source":{"system":"sec-edgar","filing":"0001843872-21-000009","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000184387221000009/edgardoc.xml","form_type":"4"}},{"id":2844356,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":52522,"kind":"person","name":"Haas Kevin Richard","position":1,"cik":"0001843872","reported_name":"Haas Kevin Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Technology"}}],"security":"Common Stock","published_at":"2021-02-22T21:38:27.000Z","date":"2021-02-18","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Consists of restricted stock units granted pursuant to the Company's 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests 25% on February 18, 2022, 25% on February 18, 2023, 25% on February 18, 2024, and 25% on February 18, 2025."}],"balance_after":42443,"source":{"system":"sec-edgar","filing":"0001843872-21-000006","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000184387221000006/edgardoc.xml","form_type":"4"}}]}